decisionhealth Newsletters, Coder Pink Sheets - 2008 Issue 1 (January)
CMS adds new sign up period for CAP, includes Orthovisc on list
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare program update affecting physician practices that participate in CMS’s Competitive Acquisition Program for injectable or infused drugs. It covers enrollment timing, program participation changes, and the addition of a product to the program’s drug list. The piece is relevant to physicians, practice managers, and medical billing professionals who follow CMS drug acquisition and administration policy.
Why This Topic Matters
The update may affect how physician practices access certain injectable drugs, manage Medicare billing workflow, and decide whether to participate in or exit the program. It also highlights a CMS change to the CAP drug roster and a new sign-up opportunity that practices may need to monitor.
What You Will Learn
- What the Competitive Acquisition Program is for physician practices
- What CMS changed about enrollment timing for the program
- What types of program participation updates were announced
- Which general drug categories are addressed in the update
- Who would likely need to track this CMS notice
Who Should Read This
- Physicians
- Medical practice managers
- Professional medical coders
- Billing staff
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com